
The objective of this study was to determine the effects of very high cost patients on hospice financial zzso Ten Pennsylvania zzso zzso certified by Medicare were randomly selected and agreed to zzso Patient age, sex, diagnosis, length of stay and payer were fairly uniform across zzso zzso varied by diagnosis and zzso High cost patients were zzso found in zzso low cost patients were commonly and regularly zzso Every hospice had at least one high cost zzso In one, the zzso payment for the zzso percent of patients defined as high cost zzso and above) would have been zzso percent of total annual zzso In another, zzso payments for high cost patients zzso percent) would have accounted for zzso percent of zzso In zzso percent of the instances patients zzso less than the Medicare Hospice Benefit maximum allowable cost zzso and, zzso percent of the time patients stayed less than the maximum allowable length of time of 210 zzso A zzso zzso model found long length of stay zzso zzso zzso Medicare hospice benefit as primary payer zzso zzso zzso any hospitalization during hospice stay zzso zzso zzso and cerebrovascular disease diagnosis zzso zzso zzso to be significantly related to high zzso Between the time the study was planned and completed, Medicare instituted a reinsurance program allowing unused funds below the maximum allowable limit from one patient to be used for patients who exhausted their zzso Thus, no study hospice was adversely affected by high cost zzso However, it should serve as an object lesson to Medicare in using prospective zzso zzso AT 250 zzso 

